CC BY-NC-ND 4.0 · Journal of Diabetes and Endocrine Practice 2024; 07(04): 156-167
DOI: 10.1055/s-0044-1791485
Review Article

Thyroxine Replacement Therapy during Ramadan Fasting: A Narrative Review

1   Department of Endocrinology, Tawam Hospital, Al Ain, United Arab Emirates
2   Internal Medicine Department, College of Medicine and Health Sciences, United Arab Emirates University, Al Ain, United Arab Emirates
,
3   College of Medicine, King Saud Bin Abdulaziz University for Health Sciences, Jeddah, Saudi Arabia
4   King Abdullah International Medical Research Center, Jeddah, Saudi Arabia
5   Department of Medicine, King Abdulaziz Medical City, Jeddah, Ministry of National Guard-Health Affairs, Jeddah, Saudi Arabia
,
6   Endocrinology Unit, Alexandria Faculty of Medicine, Alexandria University, Khartoum Square, Azarita, Alexandria, Egypt
,
7   Diabetes Unit, Department of Internal Medicine, Dubai Academic Health Corporation, Dubai, United Arab Emirates
8   Department of Medicine, Dubai Medical College, Dubai, United Arab Emirates
,
Syed Abbas Raza
9   Shaukat Khanum Cancer Hospital and Research Center, Lahore, Pakistan
,
8   Department of Medicine, Dubai Medical College, Dubai, United Arab Emirates
› Author Affiliations

Abstract

Introduction Ramadan fasting-induced changes in eating and sleeping patterns pose a risk of influencing thyroid hormone levels. There is a recognition of the potential impact of fasting and feasting on levothyroxine (L-T4) absorption.

Materials and Methods A narrative, nonsystematic literature review from two major medical online databases (PubMed and Google Scholar) from their inception to the search day (February 22, 2024). A relevant combined search term was used. The retrieved literature is narrated in a concise account.

Results There is a relationship between metabolism and thyroid-stimulating hormone (TSH). This relationship contributes to transient metabolic disturbances that influence the pharmacodynamics and pharmacokinetics of various drugs, adding complexity to the management of hypothyroidism during Ramadan fasting. Several observational studies have studied the changes in thyroid function levels during unmodified L-T4 regimens. Experimental trials explored the impact on body weight, well-being, and thyroid functions when the timing of L-T4 administration changes. Findings are far from homogeneous due to different study protocols. A recent meta-analysis demonstrated a significant post-Ramadan increase in TSH levels among euthyroid patients. L-T4 timing points, encompassing pre-Iftar, post-Iftar, and pre-Suhoor, are associated with elevated TSH levels after Ramadan fasting. The emphasis on individualized L-T4 regimens during Ramadan fasting is underscored, with recommendations for patients to refrain from food for at least 3 hours before and 30 minutes after L-T4 intake to ensure optimal compliance by most experts. The association between adherence to L-T4 during Ramadan fasting and maintaining euthyroid status is highlighted, encouraging patients to follow prescribed regimens diligently. Modified dosing frequencies, such as weekly regimens, exhibit promising results, especially in patients grappling with compliance issues. Proactive consultations with physicians before Ramadan are needed to review the latest thyroid function test and make possible dose adjustments.

Conclusion Managing hypothyroidism during Ramadan necessitates an understanding of medication timing, food-drug interactions, and prior regimens. Adherence, facilitated by flexibility, plays a critical role in achieving euthyroid status.

Authors' Contributions

S.A.B. proposed the study, performed the literature searches, and drafted the manuscript. All authors reviewed the document for intellectual content and approved its final version.


Financial Support and Sponsorship

None.


Compliance with Ethical Principles

No ethical approval is required.


Disclaimer

To the best of our abilities, we presented our perception of the published work in good faith. Original authors cannot be held responsible for any misrepresentation.




Publication History

Article published online:
30 September 2024

© 2024. Gulf Association of Endocrinology and Diabetes (GAED). This is an open access article published by Thieme under the terms of the Creative Commons Attribution-NonDerivative-NonCommercial License, permitting copying and reproduction so long as the original work is given appropriate credit. Contents may not be used for commercial purposes, or adapted, remixed, transformed or built upon. (https://creativecommons.org/licenses/by-nc-nd/4.0/)

Thieme Medical and Scientific Publishers Pvt. Ltd.
A-12, 2nd Floor, Sector 2, Noida-201301 UP, India

 
  • References

  • 1 Beshyah S, Fathalla W, Saleh A. Mini-symposium: Ramadan fasting and the medical patient: an overview for clinicians. Ibnosina J Med Biomed Sci 2010; 2 (05) 240-257
  • 2 Chaker L, Bianco AC, Jonklaas J, Peeters RP. Hypothyroidism. Lancet 2017; 390 (10101): 1550-1562
  • 3 Wiesner A, Gajewska D, Paśko P. Levothyroxine interactions with food and dietary supplements-a systematic review. Pharmaceuticals (Basel) 2021; 14 (03) 206
  • 4 Bach-Huynh TG, Nayak B, Loh J, Soldin S, Jonklaas J. Timing of levothyroxine administration affects serum thyrotropin concentration. J Clin Endocrinol Metab 2009; 94 (10) 3905-3912
  • 5 Beshyah S, Fiad T, Saadi H. Management of common endocrine conditions other than diabetes mellitus during Ramadan fasting. Ibnosina J Med Biomed Sci 2012; 04 (04) 137-146
  • 6 Raza SA, Ishtiaq O, Unnikrishnan AG. et al. Thyroid diseases and Ramadan. Indian J Endocrinol Metab 2012; 16 (04) 522-524
  • 7 Azizi F. Islamic fasting and thyroid hormones. Int J Endocrinol Metab 2015; 13 (02) e29248
  • 8 Hameed M, Raza SA. Management of thyroid diseases and steroid replacement in Ramadan: a review study. J Fasting Health 2016; 4 (02) 70-74
  • 9 Lipp HP. Administration and Pharmacokinetics of Levothyroxine. 2021 Mar 12. In: Kahaly GJ. editor 70 Years of Levothyroxine [Internet]. Cham (CH): Springer; 2021
  • 10 Caron P, Grunenwald S, Persani L, Borson-Chazot F, Leroy R, Duntas L. Factors influencing the levothyroxine dose in the hormone replacement therapy of primary hypothyroidism in adults. Rev Endocr Metab Disord 2022; 23 (03) 463-483
  • 11 Jonklaas J. Optimal thyroid hormone replacement. Endocr Rev 2022; 43 (02) 366-404
  • 12 Fedail SS, Murphy D, Salih SY, Bolton CH, Harvey RF. Changes in certain blood constituents during Ramadan. Am J Clin Nutr 1982; 36 (02) 350-353
  • 13 Sulimani RA. The effects of Ramadan fasting on thyroid functions in healthy male subjects. Nutr Res 1988; 8 (05) 549-552
  • 14 Sajid KM, Akhtar M, Malik GQ. Ramadan fasting and thyroid hormone profile. J Pak Med Assoc 1991; 41 (09) 213-216
  • 15 Bogdan A, Bouchareb B, Touitou Y. Ramadan fasting alters endocrine and neuroendocrine circadian patterns. Meal-time as a synchronizer in humans?. Life Sci 2001; 68 (14) 1607-1615
  • 16 Bahrayni S, Vakili R, Nematy M. et al. The effect of Ramadan fasting on thyroid hormones in 9–13 years old pre-menarche girls. J Fasting Health 2013; 1 (02) 46-52
  • 17 Karoli R, Fatima J, Chandra A, Mishra PP. Levothyroxine replacement and Ramadan fasting. Indian J Endocrinol Metab 2013; 17 (02) 318-319
  • 18 El-Kaissi S, Dajani R, Lee-St John TJ. et al. Impact of lifestyle changes during Ramadan on thyroid function tests in hypothyroid patients taking levothyroxine. Endocr Pract 2020; 26 (07) 748-753
  • 19 Dellal FD, Ogmen B, Ozdemir D. et al. Effect of Ramadan fasting on thyroid hormone levels in patients on levothyroxine treatment. J Coll Physicians Surg Pak 2020; 30 (10) 1009-1014
  • 20 Alkaf B, Siddiqui M, Ali T. et al. Ramadan fasting and changes in thyroid function in hypothyroidism: identifying patients at risk. Thyroid 2022; 32 (04) 368-375
  • 21 Elsherbiny TM. Impact of fasting on thyrotropin and thyroid status during Ramadan in 292 previously well controlled hypothyroid patients. IFTAR study. Endocrine 2023; 79 (03) 484-490
  • 22 Hossain S, Banerjee M, Mondal S. et al. A comparative study on effect of evening versus morning intake of levothyroxine in patients of hypothyroidism. Thyroid Research and Practice 2018; 15 (02) 89-93
  • 23 Dabbous Z, Alowainati B, Darwish S. et al. A prospective study comparing two-time points of thyroid hormone replacement during the holy month of Ramadan. Int J Endocrinol 2019; 2019: 9843961
  • 24 Zaboon IA, Alidrisi HA, Hussein IH. et al. Best time for levothyroxine intake in Ramadan (THYRAM): Basrah experience. Int J Endocrinol Metab 2020; 18 (02) e94325
  • 25 El-Kaissi S, AbdelWareth L, Dajani R. et al. Levothyroxine administration during Ramadan: a prospective randomized controlled trial. Eur Thyroid J 2021; 10 (06) 455-460
  • 26 Ghaffar T, Zulfania, Ahmad I. et al. Effect of the timing of thyroxine intake on thyroid stimulating hormone levels in Ramadan. P J M H S 2021; 15 (01) 46-48
  • 27 Al-Qahtani KM, Aldeeri IA, Alshaibi AM. et al. Optimal timing of thyroid hormone replacement during Ramadan fasting: a randomized controlled trial in patients with prior total thyroidectomy. Thyroid 2022; 32 (09) 1029-1036
  • 28 Mahzari M, Al Remthi F, Ajwah I. et al. Levothyroxine timing during Ramadan: a randomized clinical trial. Int J Endocrinol 2023; 2023: 2565031
  • 29 Alamoudi RM, Nawar SM, Alharbi HS. et al. FRI527 timing of thyroxine dose during Ramadan: a randomized controlled trial. J Endocr Soc 2023; 7 (Suppl. 01) bvad114.1872
  • 30 Elsherbiny TM. Twice or thrice weekly versus daily thyroxine in hypothyroid fasting Ramadan: a pilot study. Indian J Endocrinol Metab 2022; 26 (03) 265-268
  • 31 Elsherbiny TM. Twice or thrice weekly levothyroxine provides similar rates of adherence and post-Ramadan euthyroidism compared to daily levothyroxine during Ramadan fasting. Thyroid Res 2023; 16 (01) 44
  • 32 Zakaria NA, Shahar MA. Comparison between weekly vs daily dosing L-thyroxine for the treatment of hypothyroidism in Ramadan – a pilot randomized controlled trial. Malaysian J Med Health Sci 2022; 18 (19) 49-54
  • 33 Hadjzadeh MA, Pakdel R, Hayatdavoudi P. et al. Hypothyroidism and Ramadan fasting. J Nutrition Fasting Health 2014; 2 (02) 80-83
  • 34 Or Koca A, Dağdeviren M, Altay M. Should the dose of levothyroxine be changed in hypothyroidism patients fasting during Ramadan?. Turk J Med Sci 2020; 50 (04) 784-788
  • 35 Sheikh A, Mawani M, Mahar SA. Impact of Ramadan fasting on thyroid status and quality of life in patients with primary hypothyroidism: a prospective cohort study from Karachi, Pakistan. Endocr Pract 2018; 24 (10) 882-888
  • 36 Pakdel R, Mohebbi M, Rezaie N. et al. Ramadan fasting and thyroid hormone levels in women with hypothyroidism. J Nutrition Fasting Health 2020; 8 (01) 55-60
  • 37 Chaouachi A, Coutts AJ, Wong P. et al. Haematological, inflammatory, and immunological responses in elite judo athletes maintaining high training loads during Ramadan. Appl Physiol Nutr Metab 2009; 34 (05) 907-915
  • 38 Oudghiri D, Motaib I, Elamari S. et al. Ramadan and hypothyroidism: impact of Ramadan fasting on thyroid status. Med Clin Res Open Access 2022; 3 (01) 1-5
  • 39 Beshyah SA, Khalil AB, Beshyah AS. et al. Thyroxine replacement therapy during Ramadan fasting: physicians' and patients' perceptions and practices. J Diab and Endocr Pract 2023; 6 (01) 17-24
  • 40 Belal MM, Youssef AR, Baker H. et al. Effect of Ramadan fasting on thyroid functions in hypothyroid patients taking levothyroxine: a systematic review and meta-analysis. Ir J Med Sci 2024; 193 (02) 741-753